as 07-26-2024 4:00pm EST
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
Founded: | 2008 | Country: | United States |
Employees: | N/A | City: | PRINCETON |
Market Cap: | 2.5B | IPO Year: | 2020 |
Target Price: | $46.19 | AVG Volume (30 days): | 654.4K |
Analyst Decision: | Hold | Number of Analysts: | 10 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.39 | EPS Growth: | N/A |
52 Week Low/High: | $11.81 - $19.87 | Next Earning Date: | 08-06-2024 |
Revenue: | $360,690,000 | Revenue Growth: | 4.73% |
Revenue Growth (this year): | 12.45% | Revenue Growth (next year): | 10.35% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
SMITH PATRICK F | CERT | PRESIDENT, DRUG DEV SOLUTIONS | Apr 2 '24 | Sell | $16.76 | 5,264 | $88,224.64 | 59,254 | SEC Form 4 |
SMITH PATRICK F | CERT | PRESIDENT, DRUG DEV SOLUTIONS | Apr 2 '24 | Sell | $17.72 | 649 | $11,500.28 | 58,605 | SEC Form 4 |
SMITH PATRICK F | CERT | PRESIDENT, DRUG DEV SOLUTIONS | Apr 2 '24 | Sell | $16.75 | 3,024 | $50,652.00 | 55,581 | SEC Form 4 |
SMITH PATRICK F | CERT | PRESIDENT, DRUG DEV SOLUTIONS | Apr 2 '24 | Sell | $17.67 | 328 | $5,795.76 | 55,253 | SEC Form 4 |
SMITH PATRICK F | CERT | PRESIDENT, DRUG DEV SOLUTIONS | Apr 2 '24 | Sell | $16.77 | 4,740 | $79,489.80 | 50,513 | SEC Form 4 |
SMITH PATRICK F | CERT | PRESIDENT, DRUG DEV SOLUTIONS | Apr 2 '24 | Sell | $17.77 | 422 | $7,498.94 | 50,091 | SEC Form 4 |
Traynor Richard M. | CERT | SVP AND GENERAL COUNSEL | Apr 1 '24 | Sell | $18.00 | 3,000 | $54,000.00 | 173,524 | SEC Form 4 |
Traynor Richard M. | CERT | SVP AND GENERAL COUNSEL | Mar 4 '24 | Sell | $18.28 | 3,000 | $54,840.00 | 162,368 | SEC Form 4 |
SMITH PATRICK F | CERT | PRESIDENT, DRUG DEV SOLUTIONS | Feb 20 '24 | Sell | $18.00 | 5,000 | $90,000.00 | 54,975 | SEC Form 4 |
Traynor Richard M. | CERT | SVP AND GENERAL COUNSEL | Feb 12 '24 | Sell | $18.00 | 6,000 | $108,000.00 | 165,368 | SEC Form 4 |
Traynor Richard M. | CERT | SVP AND GENERAL COUNSEL | Dec 26 '23 | Sell | $18.00 | 6,000 | $108,000.00 | 171,368 | SEC Form 4 |
CERT Breaking Stock News: Dive into CERT Ticker-Specific Updates for Smart Investing
MT Newswires
15 days ago
MT Newswires
17 days ago
GlobeNewswire
17 days ago
GlobeNewswire
24 days ago
MT Newswires
a month ago
GlobeNewswire
a month ago
Business Wire
2 months ago
GlobeNewswire
2 months ago
The information presented on this page, "CERT Certara Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.